Page last updated: 2024-11-03

prazosin and Dyspnea

prazosin has been researched along with Dyspnea in 4 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Dyspnea: Difficult or labored breathing.

Research Excerpts

ExcerptRelevanceReference
"The cardiocirculatory actions of prazosin (PZN) orally were evaluated by cardiac catheterization, forearm plethysmography, echocardiography, treadmill exercise, and symptoms in patients with advanced long-standing congestive heart failure (CHF)."8.76Management of refractory congestive heart failure with prazosin. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE, 1981)
"The long-term efficacy of the new oral vasodilator, prazosin (PZ), was evaluated in nine patients with refractory heart failure due to chronic coronary heart disease."7.65Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn ( Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A, 1977)
"The cardiocirculatory actions of prazosin (PZN) orally were evaluated by cardiac catheterization, forearm plethysmography, echocardiography, treadmill exercise, and symptoms in patients with advanced long-standing congestive heart failure (CHF)."4.76Management of refractory congestive heart failure with prazosin. ( Awan, NA; Evenson, MK; Mason, DT; Needham, KE, 1981)
"The long-term efficacy of the new oral vasodilator, prazosin (PZ), was evaluated in nine patients with refractory heart failure due to chronic coronary heart disease."3.65Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn ( Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A, 1977)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awan, NA2
Evenson, MK1
Needham, KE1
Mason, DT2
Sterz, H1
Bertel, O1
Miller, RR1
DeMaria, AN1
Maxwell, KS1
Neumann, A1

Reviews

1 review available for prazosin and Dyspnea

ArticleYear
Management of refractory congestive heart failure with prazosin.
    American heart journal, 1981, Volume: 102, Issue:3 Pt 2

    Topics: Animals; Drug Evaluation; Drug Tolerance; Dyspnea; Echocardiography; Fatigue; Heart Failure; Hemodyn

1981

Other Studies

3 other studies available for prazosin and Dyspnea

ArticleYear
[Causes of acute valve-conditioned left ventricular insufficiency-- attempt at a tabulated review].
    Wiener medizinische Wochenschrift (1946), 1984, Mar-15, Volume: 134, Issue:5

    Topics: Aortic Valve Insufficiency; Cardiac Glycosides; Dyspnea; Endocarditis, Bacterial; Humans; Hydralazin

1984
Long-term therapy with prazosin in severe chronic congestive heart failure.
    Cardiology, 1980, Volume: 65 Suppl 1

    Topics: Blood Pressure; Capillary Resistance; Dyspnea; Heart Failure; Heart Rate; Humans; Prazosin; Quinazol

1980
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
    Circulation, 1977, Volume: 56, Issue:3

    Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease;

1977